Yasuaki Enokida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yasuaki Enokida has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Hitoshi Ojima
Department of Gastroenterological Surgery, Gunma Prefectural Cancer Center, Ota, Japan
2 shared publications - Jun Imaizumi
Toyo University
2 shared publications - Kazunosuke Yamada
Department of Surgery, University of Miyazaki, Miyazaki, Miyazaki, Japan
2 shared publications - Ryuji Kato
Department of Surgery Hidaka Hospital Gunma Japan
2 shared publications - Takahiro Takada
Gastrointestinal Surgery, Gunma Prefectural Cancer Center, Ohta, Gunma, Japan
2 shared publications Izumi Takeyoshi
Division of Thoracic and Visceral Organ Surgery, Gunma University
1 shared publication
Latest Publications
- Open Access
- 1 November 2023
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 10, e50891
The Feasibility and Reliability of Upper Arm–Worn Apple Watch Heart Rate Monitoring for Surgeons During Surgery: Observational Study
Background: Health care professionals, particularly those in surgical settings, face high stress levels, impacting their well-being. Traditional monitoring methods, like using Holter electrocardiogram monitors, are impractical in the operating room, limiting the assessment of physicians’ health. Wrist-worn heart rate monitors, like the Apple Watch, offer promise but are restricted in surgeries due to sterility issues. Objective: This study aims to assess the feasibility and accuracy of using an upper arm–worn Apple Watch for heart rate monitoring during robotic-assisted surgeries, comparing its performance with that of a wrist-worn device to establish a reliable alternative monitoring site. Methods: This study used 2 identical Apple Watch Series 8 devices to monitor the heart rate of surgeons during robotic-assisted surgery. Heart rate data were collected from the wrist-worn and the upper arm–worn devices. Statistical analyses included calculating the mean difference and SD of difference between the 2 devices, constructing Bland-Altman plots, assessing accuracy based on mean absolute error and mean absolute percentage error, and calculating the intraclass correlation coefficient. Results: The mean absolute errors for the whole group and for participants A, B, C, and D were 3.63, 3.58, 2.70, 3.93, and 4.28, respectively, and the mean absolute percentage errors were 3.58%, 3.34%, 2.42%, 4.58%, and 4.00%, respectively. Bland-Altman plots and scatter plots showed no systematic error when comparing the heart rate measurements obtained from the upper arm–worn and the wrist-worn Apple Watches. The intraclass correlation coefficients for participants A, B, C, and D were 0.559, 0.651, 0.508, and 0.563, respectively, with a significance level of P<.001, indicating moderate reliability. Conclusions: The findings of this study suggest that the upper arm is a viable alternative site for monitoring heart rate during surgery using an Apple Watch. The agreement and reliability between the measurements obtained from the upper arm–worn and the wrist-worn devices were good, with no systematic error and a high level of accuracy. These findings have important implications for improving data collection and management of the physical and mental demands of operating room staff during surgery, where wearing a watch on the wrist may not be feasible.
- 1 November 2023
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 10, e50891
Open AccessThe Feasibility and Reliability of Upper Arm–Worn Apple Watch Heart Rate Monitoring for Surgeons During Surgery: Observational Study
Background: Health care professionals, particularly those in surgical settings, face high stress levels, impacting their well-being. Traditional monitoring methods, like using Holter electrocardiogram monitors, are impractical in the operating room, limiting the assessment of physicians’ health. Wrist-worn heart rate monitors, like the Apple Watch, offer promise but are restricted in surgeries due to sterility issues. Objective: This study aims to assess the feasibility and accuracy of using an upper arm–worn Apple Watch for heart rate monitoring during robotic-assisted surgeries, comparing its performance with that of a wrist-worn device to establish a reliable alternative monitoring site. Methods: This study used 2 identical Apple Watch Series 8 devices to monitor the heart rate of surgeons during robotic-assisted surgery. Heart rate data were collected from the wrist-worn and the upper arm–worn devices. Statistical analyses included calculating the mean difference and SD of difference between the 2 devices, constructing Bland-Altman plots, assessing accuracy based on mean absolute error and mean absolute percentage error, and calculating the intraclass correlation coefficient. Results: The mean absolute errors for the whole group and for participants A, B, C, and D were 3.63, 3.58, 2.70, 3.93, and 4.28, respectively, and the mean absolute percentage errors were 3.58%, 3.34%, 2.42%, 4.58%, and 4.00%, respectively. Bland-Altman plots and scatter plots showed no systematic error when comparing the heart rate measurements obtained from the upper arm–worn and the wrist-worn Apple Watches. The intraclass correlation coefficients for participants A, B, C, and D were 0.559, 0.651, 0.508, and 0.563, respectively, with a significance level of P<.001, indicating moderate reliability. Conclusions: The findings of this study suggest that the upper arm is a viable alternative site for monitoring heart rate during surgery using an Apple Watch. The agreement and reliability between the measurements obtained from the upper arm–worn and the wrist-worn devices were good, with no systematic error and a high level of accuracy. These findings have important implications for improving data collection and management of the physical and mental demands of operating room staff during surgery, where wearing a watch on the wrist may not be feasible.
- Open Access
- 16 July 2023
- Published by JMIR Publications Inc. in JMIR Preprints
The Feasibility and Reliability of Upper Arm–Worn Apple Watch Heart Rate Monitoring for Surgeons During Surgery: Observational Study (Preprint)
BACKGROUND Health care professionals, particularly those in surgical settings, face high stress levels, impacting their well-being. Traditional monitoring methods, like using Holter electrocardiogram monitors, are impractical in the operating room, limiting the assessment of physicians’ health. Wrist-worn heart rate monitors, like the Apple Watch, offer promise but are restricted in surgeries due to sterility issues. OBJECTIVE This study aims to assess the feasibility and accuracy of using an upper arm–worn Apple Watch for heart rate monitoring during robotic-assisted surgeries, comparing its performance with that of a wrist-worn device to establish a reliable alternative monitoring site. METHODS This study used 2 identical Apple Watch Series 8 devices to monitor the heart rate of surgeons during robotic-assisted surgery. Heart rate data were collected from the wrist-worn and the upper arm–worn devices. Statistical analyses included calculating the mean difference and SD of difference between the 2 devices, constructing Bland-Altman plots, assessing accuracy based on mean absolute error and mean absolute percentage error, and calculating the intraclass correlation coefficient. RESULTS The mean absolute errors for the whole group and for participants A, B, C, and D were 3.63, 3.58, 2.70, 3.93, and 4.28, respectively, and the mean absolute percentage errors were 3.58%, 3.34%, 2.42%, 4.58%, and 4.00%, respectively. Bland-Altman plots and scatter plots showed no systematic error when comparing the heart rate measurements obtained from the upper arm–worn and the wrist-worn Apple Watches. The intraclass correlation coefficients for participants A, B, C, and D were 0.559, 0.651, 0.508, and 0.563, respectively, with a significance level of P<.001, indicating moderate reliability. CONCLUSIONS The findings of this study suggest that the upper arm is a viable alternative site for monitoring heart rate during surgery using an Apple Watch. The agreement and reliability between the measurements obtained from the upper arm–worn and the wrist-worn devices were good, with no systematic error and a high level of accuracy. These findings have important implications for improving data collection and management of the physical and mental demands of operating room staff during surgery, where wearing a watch on the wrist may not be feasible.
- 16 July 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Feasibility and Reliability of Upper Arm–Worn Apple Watch Heart Rate Monitoring for Surgeons During Surgery: Observational Study (Preprint)
BACKGROUND Health care professionals, particularly those in surgical settings, face high stress levels, impacting their well-being. Traditional monitoring methods, like using Holter electrocardiogram monitors, are impractical in the operating room, limiting the assessment of physicians’ health. Wrist-worn heart rate monitors, like the Apple Watch, offer promise but are restricted in surgeries due to sterility issues. OBJECTIVE This study aims to assess the feasibility and accuracy of using an upper arm–worn Apple Watch for heart rate monitoring during robotic-assisted surgeries, comparing its performance with that of a wrist-worn device to establish a reliable alternative monitoring site. METHODS This study used 2 identical Apple Watch Series 8 devices to monitor the heart rate of surgeons during robotic-assisted surgery. Heart rate data were collected from the wrist-worn and the upper arm–worn devices. Statistical analyses included calculating the mean difference and SD of difference between the 2 devices, constructing Bland-Altman plots, assessing accuracy based on mean absolute error and mean absolute percentage error, and calculating the intraclass correlation coefficient. RESULTS The mean absolute errors for the whole group and for participants A, B, C, and D were 3.63, 3.58, 2.70, 3.93, and 4.28, respectively, and the mean absolute percentage errors were 3.58%, 3.34%, 2.42%, 4.58%, and 4.00%, respectively. Bland-Altman plots and scatter plots showed no systematic error when comparing the heart rate measurements obtained from the upper arm–worn and the wrist-worn Apple Watches. The intraclass correlation coefficients for participants A, B, C, and D were 0.559, 0.651, 0.508, and 0.563, respectively, with a significance level of P<.001, indicating moderate reliability. CONCLUSIONS The findings of this study suggest that the upper arm is a viable alternative site for monitoring heart rate during surgery using an Apple Watch. The agreement and reliability between the measurements obtained from the upper arm–worn and the wrist-worn devices were good, with no systematic error and a high level of accuracy. These findings have important implications for improving data collection and management of the physical and mental demands of operating room staff during surgery, where wearing a watch on the wrist may not be feasible.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA4276
LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by Eprobe-PCR method
Background: Human epidermal growth factor receptor 2(HER2) is one of the driver mutations of lung cancer. This is a rare somatic mutation, 12-bp duplicated insertion is observed the most frequently. It has been reported that anti-HER2 drugs are effective for mutant cases, suggesting the importance of HER2 mutation analysis. Sanger method is not appropriate to detect very low frequency of genetic mutation due to low sensitivity. In contrast, next generation sequencer (NGS) has much higher sensitivity. However, it needs highly specialized equipment, experts and a lot of time to analyze data. We have developed a novel assay using Eprobe-mediated PCR (Eprobe-PCR). This probe is a hybridization-dependent fluorescent oligonucleotide. We evaluated feasibility of Eprobe-PCR for HER2 mutation detection by comparing with Sanger and NGS data. Methods: We applied genomic DNA from 405 frozen samples of ADC to real-time PCR and melting curve analysis with Eprobe for identification of the 12-bp duplicated insertion. The PCR products were analyzed by Sanger capillary sequencing and HiSeq2500 NGS. From NGS data, we calculated mutation ratio in each specimen. Results: Eprobe-PCR detected the mutation in 2.47%(10/405), Sanger in 1.98%(8/405), NGS in 3.46%(14/405). According to the NGS results, Eprobe-PCR was able to detect it in the samples that mutation ratio is not less than 1%. There were no false positive results. This method has adequate-sensitivity for determination of HER2-insertion mutation within 2 hours from preparation of reaction mix. Conclusions: Eprobe-PCR is simple, rapid and highly sensitive. This can lead to be more appropriate molecular targeted therapy for HER2 mutation in lung cancer.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA4276
LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by Eprobe-PCR method
Background: Human epidermal growth factor receptor 2(HER2) is one of the driver mutations of lung cancer. This is a rare somatic mutation, 12-bp duplicated insertion is observed the most frequently. It has been reported that anti-HER2 drugs are effective for mutant cases, suggesting the importance of HER2 mutation analysis. Sanger method is not appropriate to detect very low frequency of genetic mutation due to low sensitivity. In contrast, next generation sequencer (NGS) has much higher sensitivity. However, it needs highly specialized equipment, experts and a lot of time to analyze data. We have developed a novel assay using Eprobe-mediated PCR (Eprobe-PCR). This probe is a hybridization-dependent fluorescent oligonucleotide. We evaluated feasibility of Eprobe-PCR for HER2 mutation detection by comparing with Sanger and NGS data. Methods: We applied genomic DNA from 405 frozen samples of ADC to real-time PCR and melting curve analysis with Eprobe for identification of the 12-bp duplicated insertion. The PCR products were analyzed by Sanger capillary sequencing and HiSeq2500 NGS. From NGS data, we calculated mutation ratio in each specimen. Results: Eprobe-PCR detected the mutation in 2.47%(10/405), Sanger in 1.98%(8/405), NGS in 3.46%(14/405). According to the NGS results, Eprobe-PCR was able to detect it in the samples that mutation ratio is not less than 1%. There were no false positive results. This method has adequate-sensitivity for determination of HER2-insertion mutation within 2 hours from preparation of reaction mix. Conclusions: Eprobe-PCR is simple, rapid and highly sensitive. This can lead to be more appropriate molecular targeted therapy for HER2 mutation in lung cancer.